SEC Form 4 · accession 0000905148-26-002807
RIGEL PHARMACEUTICALS INC · RIGL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Raymond J. Furey
Officer — EVP, GC, CCO & Corp Sec
Period of report
Jun 1, 2026
Accepted (ET)
Jun 3, 2026 · 6:01 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001034842
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 1, 2026 | F | 877 | $29.86 | D | 50,936 | D |
Table II — derivative securities
No Table II lines on this filing.